Overview
Rice bran arabinoxylan compound is most commonly used for boosting the immune system. It is also used for cancer, reducing side effects of cancer treatment, chronic fatigue syndrome (CFS), hepatitis C, and other conditions, but there is no good scientific evidence to support these uses.
How does it work ?
Uses & Effectiveness
Insufficient Evidence for
- Chronic fatigue syndrome (CFS). Early research suggested that rice bran arabinoxylan compound might improve symptoms and immune function in people with CFS. But more recent evidence shows that rice bran arabinoxylan compound does not improve symptoms of CFS including fatigue. All of the studies to date have been small and/or low quality, so more high quality research is needed.
- Swelling (inflammation) of the liver caused by the hepatitis C virus (hepatitis C). Early research suggests that taking rice bran arabinoxylan compound helps to clear hepatitis C virus from the bloodstream in people with a certain type of hepatitis C. It seems to work as well as pegylated interferon plus ribavirin.
- HIV/AIDS. Early research shows that taking rice bran arabinoxylan does not improve most blood markers of HIV/AIDS.
- Liver cancer. Early research shows that taking rice bran arabinoxylan compound in combination with standard therapy might help people with liver cancer live longer compared to standard therapy alone. It might also help prevent liver cancer from returning after treatment.
- Quality of life. Early research shows that taking rice bran arabinoxylan 250 mg daily for 3 months may improve self-reported quality of life in older adults.
- Boosting immune function.
- Diabetes.
- Preventing and treating cancer.
- Other conditions.
Side Effects
Special Precautions and Warnings
Pregnancy and breast-feeding: Not enough is known about the use of rice bran arabinoxylan compound during pregnancy and breast-feeding. Stay on the safe side and avoid use.
"Auto-immune diseases" such as multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), or other conditions: Rice bran arabinoxylan compound might cause the immune system to become more active. This might increase the symptoms of auto-immune diseases. If you have one of these conditions, it's best to avoid using rice bran arabinoxylan compound.
Interactions
Medications that decrease the immune system (Immunosuppressants) interacts with RICE BRAN ARABINOXYLAN COMPOUND
Rice bran arabinoxylan compound might increase the immune system. By increasing the immune system, rice bran arabinoxylan compound might decrease the effectiveness of medications that decrease the immune system.
Some medications that decrease the immune system include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.
Moderate Interaction
Be cautious with this combination
Dosing
You Might Also Like
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2020.